Compare Pfizer Inc (PFE) vs Direxion Daily S&P 500 Bull 3X Shares (SPXL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Direxion Daily S&P 500 Bull 3X Shares — how do they compare? Pfizer Inc trades at $28.1 (market cap $158.56B), while Direxion Daily S&P 500 Bull 3X Shares trades at $297.5 (market cap $7.36B). The key difference: Pfizer Inc is far larger — about 21.5× Direxion Daily S&P 500 Bull 3X Shares's market cap, and Pfizer Inc pays a 6.18% dividend while Direxion Daily S&P 500 Bull 3X Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and Direxion Daily S&P 500 Bull 3X Shares for 32 Days on average.
| PFE | SPXL | |
|---|---|---|
Market Cap | $158.56B | $7.36B |
Volume | 44,138,282 | 1,835,467 |
Sector | Health | Leveraged / Inverse |
52-Week High | $29.02 | $301.38 |
52-Week Low | $23.67 | $170.20 |
Typical Hold Time | 158 Days | 32 Days |
Enterprise Value | $210.06B | — |
Dividend Yield | 6.18% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.
The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.
SPXL trades at $296.84, down 0.79% on the day, with technical indicators showing a bullish trend supported by moving averages. The ETF maintains neutral oscillator signals while approaching key resistance at $299. Recent market sentiment reflects mixed outlooks for S&P 500 performance amid earnings growth concerns and seasonal patterns.
The leveraged ETF's performance remains tied to S&P 500 movements, with Wall Street projecting potential upside but facing headwinds from expected earnings growth slowdown. Key risks include market concentration in top holdings and geopolitical uncertainties affecting broader market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Direxion Daily S&P 500 Bull 3X Shares
SPXL aims for 300% of the S&P 500's daily performance. It uses swaps and futures to provide 3x leverage, making it a high-risk tool for short-term traders. Due to daily resets, it is prone to volatility decay and is not intended for long-term holding.
Read more on SPXL →
